RecruitingNot ApplicableNCT06027749

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.

Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With REMI.


Sponsor

Epitel, Inc.

Enrollment

65 participants

Start Date

Oct 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to test Epitel's™ Remote EEG Monitoring System's (REMI™) ability to record electroencephalography (EEG) of seizure events in an ambulatory setting for extended periods (14 - 28 days) in patients presenting with questionable seizure characterization. The main questions it aims to answer are: • Can more seizure events be recorded in fourteen (14) days than can be recorded in three (3) days? • Do treating clinicians find clinical value in extended fourteen (14) - twenty-eight (28) days of EEG? Participants will wear a portable EEG device (REMI) for fourteen (14) to twenty-eight (28) days in their home/community setting.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria7

  • Patients have a reported history of seizures (epileptic, non-epileptic, or unknown),
  • Have a minimum reported seizure rate of one every two weeks,
  • Are prescribed an ambulatory EEG study as part of routine care,
  • Is Male or Female between the ages of 18 and 70,
  • Can understand and sign written informed consent, or have a legal guardian provide consent,
  • The Patient (or Primary Caregiver) must be competent to follow all study procedures,
  • The Patient must be willing to use the System for a prolonged period (up to 30 days), for a minimum of 20 hours/day.

Exclusion Criteria4

  • Is sensitive or allergic to medical acrylics, silicones, or hydrogels,
  • Is enrolled in another investigational drug or device trial,
  • Is homeless or in a home without a power supply, or
  • Cannot read, speak, or understand English (and does not have a translator).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEpitel's™ Remote EEG Monitoring System's (REMI™)

Ambulatory electroencephalography (EEG) monitoring


Locations(2)

University of South Florida

Tampa, Florida, United States

Medical University of South Carolina

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06027749


Related Trials